APA (7th ed.) Citation

Schultheis, B., Folprecht, G., Kuhlmann, J., Ehrenberg, K. R., Hacker, U. T., Köhne, C., . . . Mross, K. (2013). Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: Results of a multicenter, phase Ib study. Annals of oncology, 24(6), . https://doi.org/10.1093/annonc/mdt056

Chicago Style (17th ed.) Citation

Schultheis, Beate, et al. "Regorafenib in Combination with FOLFOX or FOLFIRI as First- or Second-line Treatment of Colorectal Cancer: Results of a Multicenter, Phase Ib Study." Annals of Oncology 24, no. 6 (2013). https://doi.org/10.1093/annonc/mdt056.

MLA (9th ed.) Citation

Schultheis, Beate, et al. "Regorafenib in Combination with FOLFOX or FOLFIRI as First- or Second-line Treatment of Colorectal Cancer: Results of a Multicenter, Phase Ib Study." Annals of Oncology, vol. 24, no. 6, 2013, https://doi.org/10.1093/annonc/mdt056.